Atlas Trials

Efficacy Study of Rapamycin- vs. Zotarolimus-Eluting Stents to Reduce Coronary Restenosis

Clinical trial NCT00598533 · COMPLETED

Trial details

NCT number
NCT00598533
Sponsor
Deutsches Herzzentrum Muenchen
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Coronary Heart Disease
Start date
2008-02-01
Primary completion
2010-08-01
Enrollment
3002

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.